A.P. Pharma, Inc. (NASDAQ:APPA stock), a specialty pharmaceutical
company, today provided an update on the timing for the submission of
the New Drug Application (NDA) for APF530,...
A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceuticals company,
announced today it has made a stock option grant to Ronald J. Prentki,
who joined the company on...
A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical
company, has appointed Ronald J. Prentki as President, Chief Executive
Officer and a member of the company’s...
A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceuticals company,
today announced that its board of directors has initiated an executive
succession program designed to recruit...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today reported financial results for its fourth quarter and full year ended...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, will release its 2006 fourth quarter and year end financial results before...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates updates its coverage of AP Pharma (Nasdaq:APPA) with
an upgrade of its rating to Strong Speculative Buy. The 10-page report ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical
company, reported today that it believes that it will not meet a
previously...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical
company, today announced that Anastassios D. Retzios, Ph.D. has joined
the Company...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical
company, today reported financial results for the three months ended
September 30,...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical
company, will release its 2006 third quarter financial results before
the market...
REDWOOD CITY, Calif. & NEW HAVEN, Conn.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA) and RHEI Pharmaceuticals, Inc.
today announced that A.P. Pharma has granted an exclusive license to...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical
company, today announced that it expects to have initial data from its
Phase 3...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Sept. 12, 2006--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today announced it will present at the Merriman Curhan Ford "Investor...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Aug. 14, 2006--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today announced that Arthur T. Taylor has joined the Company's board of...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Aug. 8, 2006--A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today reported financial results for the three months ended June 30, 2006....
REDWOOD CITY, Calif.--(BUSINESS WIRE)--July 28, 2006--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, will release its 2006 second quarter financial results prior to market...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--June 27, 2006--Dutton Associates updates its coverage of A.P. Pharma (Nasdaq:APPA) maintaining a Strong Speculative Buy rating and a $3.00 price target....
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Nov. 16, 2005--A.P. Pharma, Inc. (NASDAQ NM: APPA), a specialty pharmaceutical company, today reported that on November 11, 2005, the Company was advised by...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Nov. 4, 2005--Dutton Associates updates its coverage of A.P. Pharma (Nasdaq:APPA) with an upgrade of its rating to Strong Speculative Buy. The 10-page...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Nov. 3, 2005--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today announced that it will present at the Rodman & Renshaw Techvest 7th...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Nov. 2, 2005--A.P. Pharma, Inc. (NASDAQ NM: APPA), a specialty pharmaceutical company, today reported financial results for the three months ended September...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 26, 2005--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, will release its 2005 third quarter financial results prior to market open...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 4, 2005--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, will hold an investment-community conference call beginning at 11:00 a.m....
#3: APPA News A.P. Pharma Reports All Clinical Endpoints Achieved in APF530 Phase 2 Trial; Conference Call to Begin at 11:00 A.M. Eastern Time Tuesday, October 4, 2005
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Sept. 29, 2005--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today reported results from its APF530 Phase 2 clinical trial. All...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Aug. 8, 2005--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today reported financial results for the three months ended June 30, 2005....
REDWOOD CITY, Calif.--(BUSINESS WIRE)--July 29, 2005--A.P. Pharma, Inc. (NASDAQ: APPA), a specialty pharmaceutical company, will release its 2005 second quarter financial results prior to market...
